Astrocytic metabolic reprogramming in Parkinson’s disease: mechanistic crosstalk and therapeutic opportunities
Abstract Parkinson’s disease (PD), a neurodegenerative disorder, is predominantly characterized by the depletion of dopaminergic neurons in the substantia nigra pars compacta and the aberrant aggregation of α-synuclein (α-syn). Recent research has indicated that astrocytes not only function as indispensable supportive...